Literature DB >> 8603345

Cytogenetic findings in mouse multiple myeloma and Waldenström's macroglobulinemia.

T W van den Akker1, J Radl, E Franken-Postma, A Hagemeijer.   

Abstract

Multiple myeloma (MM) and Waldenstrom's macroglobulinemia-like lymphoma (MW) appear spontaneously in C57BL/KaLwRij mice at a frequency of 0.5% and 0.2%, respectively. They can readily be propagated by intravenous transfer of mainly bone marrow or spleen cells into syngeneic recipients. Previous studies demonstrated that these mouse malignant monoclonal gammopathies (MMG) show clinical and biologic features that closely resemble those of the corresponding human diseases and thus could be used as experimental models. We report on cytogenetic analysis of two mouse MW and five MM in vivo cell lines of the 5TMM series propagated in syngeneic mice. These studies demonstrated clonal abnormalities in all cell lines, hyperdiploid karyotype in both MW and one MM lines, and hypotriploidy, hypertriploidy, or hypotetraploidy in the other lines. Structural abnormalities of chromosome 15 were observed in all MM lines. In five MM lines, frequent rearrangements were also found for chromosome numbers 1, 2, 5, and 12. A single chromosomal abnormality, as found in induced mouse plasmacytomas and resembling Burkitt lymphoma, was not found in mouse MM and MW. It was concluded that spontaneously originating C57BL MM of the 5T series is a better model for human MM than pristane-induced BALB/c or NZB plasmacytoma.

Entities:  

Mesh:

Year:  1996        PMID: 8603345     DOI: 10.1016/0165-4608(95)00169-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression.

Authors:  Pramod S Gowda; Benjamin J Wildman; Timothy N Trotter; Xiaoxuan Xu; Xiaoxiao Hao; Mohammad Q Hassan; Yang Yang
Journal:  Mol Cancer Res       Date:  2018-03-28       Impact factor: 5.852

2.  Myeloma cell-derived Runx2 promotes myeloma progression in bone.

Authors:  Timothy N Trotter; Mei Li; Qianying Pan; Deniz Peker; Patrick D Rowan; Juan Li; Fenghuang Zhan; Larry J Suva; Amjad Javed; Yang Yang
Journal:  Blood       Date:  2015-04-10       Impact factor: 22.113

3.  Immunoglobulin VH gene sequence analysis of spontaneous murine immunoglobulin-secreting B-cell tumours with clinical features of human disease.

Authors:  D Zhu; C van Arkel; C A King; S V Meirvenne; C de Greef; K Thielemans; J Radl; F K Stevenson
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

4.  Detection of myeloma in skeleton of mice by whole-body optical fluorescence imaging.

Authors:  Babatunde O Oyajobi; Steve Muñoz; Rami Kakonen; Paul J Williams; Anjana Gupta; Christi L Wideman; Beryl Story; Barry Grubbs; Allison Armstrong; William C Dougall; I Ross Garrett; Gregory R Mundy
Journal:  Mol Cancer Ther       Date:  2007-05-31       Impact factor: 6.261

5.  Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4.

Authors:  Leonardo Mirandola; Yuefei Yu; Marjorie R Jenkins; Raffaella Chiaramonte; Everardo Cobos; Constance M John; Maurizio Chiriva-Internati
Journal:  BMC Cancer       Date:  2011-09-16       Impact factor: 4.430

Review 6.  Mouse models of multiple myeloma: technologic platforms and perspectives.

Authors:  Marco Rossi; Cirino Botta; Mariamena Arbitrio; Rosa Daniela Grembiale; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Oncotarget       Date:  2018-04-13

7.  The genetic landscape of 5T models for multiple myeloma.

Authors:  Ken Maes; Bram Boeckx; Philip Vlummens; Kim De Veirman; Eline Menu; Karin Vanderkerken; Diether Lambrechts; Elke De Bruyne
Journal:  Sci Rep       Date:  2018-10-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.